Cargando…

Carvedilol modifies antioxidant status of patients with stable angina

The aim of this study was to evaluate the effect of carvedilol on the enzymatic antioxidative defence and plasma antioxidative activity in patients with stable angina. The study comprised 30 patients, aged 37–49 years with stable angina. Patients received carvedilol in escalating doses of 12.5 mg/24...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalski, Jan, Banach, Maciej, Barylski, Marcin, Irzmanski, Robert, Pawlicki, Lucjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SP Versita 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275870/ https://www.ncbi.nlm.nih.gov/pubmed/18026857 http://dx.doi.org/10.2478/s11658-007-0049-3

Ejemplares similares

N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients
por: Piechota, Mariusz, et al.
Publicado: (2006)

Stable Angina
por: Dobesh, Paul P.
Publicado: (2006)

Functional status and life satisfaction of patients with stable angina pectoris in Austria
por: Spinka, Fabian, et al.
Publicado: (2019)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Lipids, blood pressure, kidney – what was new in 2011?
por: Barylski, Marcin, et al.
Publicado: (2011)

Investigation and Management of Stable Angina
por: Underwood, Richard, et al.
Publicado: (1993)

Investigation and Management of Stable Angina
por: Clarke, S E M
Publicado: (1993)

Advances in the Management of Stable Angina
por: Trujillo, Toby C.
Publicado: (2006)

Impact of angina frequency on health utility values of patients with chronic stable angina
por: Kohn, Christine G, et al.
Publicado: (2014)

Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008)

Management of a patient with chronic stable angina
por: Fox, Kim
Publicado: (2019)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Risk factors in blood for attacks of angina in patients with coronavirus disease 2019 and stable angina
por: Geng, Song, et al.
Publicado: (2023)

Urine proteomics in the diagnosis of stable angina
por: Neisius, Ulf, et al.
Publicado: (2016)

Coronary revascularization in the elderly with stable angina
por: Kozlov, Kirill Lenarovich, et al.
Publicado: (2015)

Re chronic stable angina guidelines
por: Gupta, Prabha Nini, et al.
Publicado: (2017)

Resistin and prooxidant-antioxidant balance: Markers to discriminate acute coronary syndrome from stable angina
por: Pourmoghaddas, Ali, et al.
Publicado: (2020)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Effectiveness of Ivabradine in Treating Stable Angina Pectoris
por: Ye, Liwen, et al.
Publicado: (2016)

Ivabradine for the Therapy of Chronic Stable Angina Pectoris
por: Kim, Soo-Joong
Publicado: (2020)

Evaluation of Leptin and Adiponectin Levels in Patients with Stable Angina Pectoris
por: Mozafari, Masoud, et al.
Publicado: (2010)

Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries
por: Lanza, Gaetano Antonio
Publicado: (2019)

Outcomes after coronary angiography for unstable angina compared to stable angina, myocardial infarction and an asymptomatic general population
por: Fladseth, Kristina, et al.
Publicado: (2022)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

The role of polysaccharide peptide of Ganoderma lucidum as a potent antioxidant against atherosclerosis in high risk and stable angina patients
por: Sargowo, Djanggan, et al.
Publicado: (2018)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Not So Stable Angina: Single Coronary Artery Disease
por: Thangjui, Sittinun, et al.
Publicado: (2022)

Carvedilol Enhances the Antioxidant Effect of Vitamins E and C in Chronic Chagas Heart Disease
por: Budni, Patrícia, et al.
Publicado: (2013)

The Material Basis and Mechanism of Xuefu Zhuyu Decoction in Treating Stable Angina Pectoris and Unstable Angina Pectoris
por: Qi, Guanpeng, et al.
Publicado: (2022)

Evaluating Symptoms to Improve Quality of Life in Patients with Chronic Stable Angina
por: Young, Jeffrey W., et al.
Publicado: (2013)

Chest pain after percutaneous coronary intervention in patients with stable angina
por: Chang, Chao-Chien, et al.
Publicado: (2016)

Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis
por: Ohde Dalledone, Giuliano, et al.
Publicado: (2016)

Role of ivabradine in management of stable angina in patients with different clinical profiles
por: Kaski, Juan Carlos, et al.
Publicado: (2018)

Patient-Clinician Decision Making for Stable Angina: The Role of Health Literacy
por: Savitz, Samuel T., et al.
Publicado: (2019)

Circulating MicroRNA Expression Profiles in Patients with Stable and Unstable Angina
por: Liu, Sudong, et al.
Publicado: (2020)

Is it possible that angioplasty does not improve the quality of life in patients with stable angina?
por: Golino, Paolo
Publicado: (2022)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study
por: Ayashi, Saleh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9q0ua7f4tje1ba1jalgt1j3r3q